iQ&A for Familial Hypercholesterolemia – Part II
iQ&A for Familial Hypercholesterolemia – Part I
iQ&A for Diabetes and CVD
iQ&A for Obesity Management
iQ&A for Advances in SPAF
iQ&A for Recent Advances in AF
iQ&A for SPAF Trials: UPDATE
iQ&A for Thrombosis Risk Reduction
iQ&A for Stroke Prevention in AF
iQ&A for Familial Hypercholesterolemia – Part II
iQ&A for Familial Hypercholesterolemia – Part I
iQ&A for Advances in SPAF
iQ&A for Recent Advances in AF
iQ&A for SPAF Trials: UPDATE
iQ&A for Thrombosis Risk Reduction
iQ&A for Stroke Prevention in AF
iQ&A for Obesity Management
iQ&A for Advances in SPAF
iQ&A for Recent Advances in AF
iQ&A for Alzheimer’s Disease
iQ&A for SPAF Trials: UPDATE
iQ&A for Stroke Prevention in AF
iQ&A for Multiple Sclerosis
iQ&A for Familial Hypercholesterolemia – Part II
iQ&A for Familial Hypercholesterolemia – Part I
iQ&A for Diabetes and CVD
iQ&A for Obesity Management
iQ&A for Type 2 Diabetes
iQ&A for Rheumatoid Arthritis
iQ&A for Breast Cancer
iQ&A for Obesity Management
iQ&A for Alzheimer’s Disease
iQ&A for Familial Hypercholesterolemia – Part II
iQ&A for Familial Hypercholesterolemia – Part I
iQ&A for Diabetes and CVD
iQ&A for Obesity Management
iQ&A for Alzheimer’s Disease
iQ&A for Type 2 Diabetes
Cardiology
ACS-WRAP
: Focus on Oral Antiplatelet Therapy for Medical Management of ACS.
Presenter:
Charles V. Pollack, Jr. MD, MA, FACEP, FAAEM, FAHA
AtrialFibrillationWRAP
: Focus on Rhythm Control and Optimizing Outcome Domains in Patients with AF.
Presenter:
Gerald V. Naccarelli, MD
AntiplateletWRAP
: Oral Antiplatelet Therapy and Proton Pump Inhibitors in the Setting of ACS and CAD.
Presenter:
Deepak L. Bhatt, MD
CardioContrastWRAP
: The Role of Ionic, Low Osmolar Contrast Media (LOCM) for Thrombosis Reduction in the Setting of PCI.
Presenter:
Steven Manoukian, MD, FACC, FSCAI
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—DVT Risk Assessment and Pharmacologic Intervention Upon Hospital Admission (Part I).
Presenter:
Samuel Z. Goldhaber, MD
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—Dynamic VTE Risk Assessment During Hospital Admission (Part II).
Presenter:
Samuel Z. Goldhaber, MD
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—LMWH-based Prophylaxis in the Post-Hospitalization Phase (Part III).
Presenter:
Samuel Z. Goldhaber, MD
AntiplateletWRAP
: Oral Antiplatelet Therapy in the Setting of ACS—Focus on Thienopyridines and CABG Surgery.
Presenter:
Dr. Sunil V. Rao, MD, FACC
ACS-WRAP
: Applying Landmark Evidence to Interventional Management of Patients with High Risk Acute Coronary Syndromes (ACS)—Integrating Bivalirudin into Practice Algorithms for ACS and STEMI.
Presenter:
Harold L. Dauerman, MD, FACC
STEMI-WRAP
: The Landmark HORIZONS-AMI Trial—Bleeding and Attributable Death Analysis.
Presenter:
Gregg W. Stone, MD, FACC
STEMI-WRAP
: Focus on Oral Antiplatelet Therapy in the Setting of STEMI—Eviidence-Based Use of Thienopyridines in the Emergency Department.
Presenter:
Charles V. Pollack, Jr. MA, MD, FACEP, FAAEM, FAHA
ACS-WRAP
: Focus on Oral Antiplatelet Therapy for NSTE-ACS—Guildeine-Consistent Use of Thienopyridines.
Presenter:
Charles V. Pollack, Jr. MA, MD, FACEP, FAAEM, FAHA
Thrombosis
ACS-WRAP
: Focus on Oral Antiplatelet Therapy for Medical Management of ACS.
Presenter:
Charles V. Pollack, Jr. MD, MA, FACEP, FAAEM, FAHA
AtrialFibrillationWRAP
: Focus on Rhythm Control and Optimizing Outcome Domains in Patients with AF.
Presenter:
Gerald V. Naccarelli, MD
AntiplateletWRAP
: Oral Antiplatelet Therapy and Proton Pump Inhibitors in the Setting of ACS and CAD.
Presenter:
Deepak L. Bhatt, MD
CardioContrastWRAP
: The Role of Ionic, Low Osmolar Contrast Media (LOCM) for Thrombosis Reduction in the Setting of PCI.
Presenter:
Steven Manoukian, MD, FACC, FSCAI
VTECancerWRAP
: Optimizing Clinical Outcomes for Venous Thromboembolism (VTE) in the Patient with Cancer.
Presenter:
Craig M. Kessler, MD, MACP
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—DVT Risk Assessment and Pharmacologic Intervention Upon Hospital Admission (Part I).
Presenter:
Samuel Z. Goldhaber, MD
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—Dynamic VTE Risk Assessment During Hospital Admission (Part II).
Presenter:
Samuel Z. Goldhaber, MD
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—LMWH-based Prophylaxis in the Post-Hospitalization Phase (Part III).
Presenter:
Samuel Z. Goldhaber, MD
AntiplateletWRAP
: Oral Antiplatelet Therapy in the Setting of ACS—Focus on Thienopyridines and CABG Surgery.
Presenter:
Dr. Sunil V. Rao, MD, FACC
ACS-WRAP
: Applying Landmark Evidence to Interventional Management of Patients with High Risk Acute Coronary Syndromes (ACS)—Integrating Bivalirudin into Practice Algorithms for ACS and STEMI.
Presenter:
Harold L. Dauerman, MD, FACC
STEMI-WRAP
: The Landmark HORIZONS-AMI Trial—Bleeding and Attributable Death Analysis.
Presenter:
Gregg W. Stone, MD, FACC
DiabetesWRAP
: Focus on 1,5-Anhydroglucitol (AG) for Monitoring and Clinical Management of Patients with Diabetes.
Presenter:
Steven D. Wittlin, MD
STEMI-WRAP
: Focus on Oral Antiplatelet Therapy in the Setting of STEMI—Eviidence-Based Use of Thienopyridines in the Emergency Department.
Presenter:
Charles V. Pollack, Jr. MA, MD, FACEP, FAAEM, FAHA
ACS-WRAP
: Focus on Oral Antiplatelet Therapy for NSTE-ACS—Guildeine-Consistent Use of Thienopyridines.
Presenter:
Charles V. Pollack, Jr. MA, MD, FACEP, FAAEM, FAHA
Diagnostic Medicine
ColonCancerWRAP
: Improving Diagnosis, Screening, and Outcomes in Colorectal Cancer.
Presenter:
Richard C. Wender, MD
GeneticScreeningWRAP
: Prenatal Screening for Genetic Disorders.
Presenter:
Wayne W. Grody, MD, PhD
OvarianCancerWRAP
: Improving Diagnosis and Referral of Women with Ovarian Cancer.
Presenter:
Fred R. Ueland, MD
VitaminD-WRAP
: Optimizing Identification of Patients and Laboratory Testing for Vitamin D Deficiency.
Presenter:
Michael Hollick, PhD, MD
MultipleSclerosisWRAP
: The Evolving Science and Medicine of Multiple Sclerosis Management—Focus on Diagnostic Issues and Long-Term Outcomes.
Presenter:
Jerry S. Wolinsky, MD
DiabetesWRAP
: Focus on 1,5-Anhydroglucitol (AG) for Monitoring and Clinical Management of Patients with Diabetes.
Presenter:
Steven D. Wittlin, MD
STI-WRAP
: Screening and Diagnosis of Sexually Transmitted Infections: Focus on Chlamydial Infections.
Presenter:
William M. Geisler, MD, MPH
KidneyStoneWRAP
: Diagnosis, Metabolic Risk Assessment and Long-Term Monitoring of Patients with Kidney Stones.
Presenter:
Glenn M. Preminger, MD
AsthmaWRAP
: NIH Asthma Guidelines—Laboratory Techniques for Identifying Allergic Triggers.
Presenter:
Leonard Fromer, MD, FAAFP
Oncology
ColonCancerWRAP
: Improving Diagnosis, Screening, and Outcomes in Colorectal Cancer.
Presenter:
Richard C. Wender, MD
OvarianCancerWRAP
: Improving Diagnosis and Referral of Women with Ovarian Cancer.
Presenter:
Fred R. Ueland, MD
CINV-WRAP
: Optimizing Therapy and Current Guidelines for Chemotherapy-Induced Nausea and Vomiting (CINV).
Presenter:
Lee S. Schwartzberg, MD, FACP
VTECancerWRAP
: Optimizing Clinical Outcomes for Venous Thromboembolism (VTE) in the Patient with Cancer.
Presenter:
Craig M. Kessler, MD, MACP
Neurology
MultipleSclerosisWRAP
: Immunomodulation Therapy for Multiple Sclerosis.
Presenter:
Bruce A. Cree, MD, PhD
MultipleSclerosisWRAP
: Evolution of Neurotherapeutic Agents for Multiple Sclerosis.
Presenter:
Douglas R. Jeffery, MD, PhD
Alzheimer’sWRAP
: The Foundation Role of Cholinergic Dysregulation in AD.
Presenter:
Jeffrey L. Cummings, MD
MultipleSclerosisWRAP
: Optimizing Clinical Outcomes in Multiple Sclerosis—Focus on Enduring Remissions and Poor Responders to Immune Modulating Therapy.
Presenter:
Patricia Coyle, MD
MultipleSclerosisWRAP
: The Evolving Science and Medicine of Multiple Sclerosis Management—Focus on Diagnostic Issues and Long-Term Outcomes.
Presenter:
Jerry S. Wolinsky, MD
FibromyalgiaWRAP
: Landmark Trials, Clinical Challenges, and Practice Advances for FM Syndrome—Focus on Dual Reuptake Inhibition.
Presenter:
Don L. Goldenberg, MD
OAB-WRAP
: Focus on Early, Evidence-Based Management of Overactive Bladder—The Foundation Role of Muscarinic Receptor Antagonists.
Presenter:
David R. Staskin, MD
Parkinson'sWRAP:
: The Foundation Role of MAO-B Inhibitors in Parkinson’s Disease.
Presenter:
Lawrence W. Elmer, MD, PhD
Parkinson'sWRAP
: Landmark Advances in Parkinson's Disease.
Presenter:
C. Warren Olanow, MD, FRCPC
Primary Care
Alzheimer’sWRAP
: The Foundation Role of Cholinergic Dysregulation in AD.
Presenter:
Jeffrey L. Cummings, MD
GeneticScreeningWRAP
: Prenatal Screening for Genetic Disorders.
Presenter:
Wayne W. Grody, MD, PhD
OvarianCancerWRAP
: Improving Diagnosis and Referral of Women with Ovarian Cancer.
Presenter:
Fred R. Ueland, MD
VitaminD-WRAP
: Optimizing Identification of Patients and Laboratory Testing for Vitamin D Deficiency.
Presenter:
Michael Hollick, PhD, MD
VTECancerWRAP
: Optimizing Clinical Outcomes for Venous Thromboembolism (VTE) in the Patient with Cancer.
Presenter:
Craig M. Kessler, MD, MACP
OsteoporosisWRAP
: Evidence-Based and Practical Approaches to Bisphosphonate Therapy.
Presenter:
Sol Epstein, MD
OsteoporosisWRAP
: Optimizing Fracture Reduction in Osteoporosis—The Role of Annual Cumulative Exposure with Bisphosphonates.
Presenter:
Steven D. Harris, MD, FACP
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—DVT Risk Assessment and Pharmacologic Intervention Upon Hospital Admission (Part I).
Presenter:
Samuel Z. Goldhaber, MD
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—Dynamic VTE Risk Assessment During Hospital Admission (Part II).
Presenter:
Samuel Z. Goldhaber, MD
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—LMWH-based Prophylaxis in the Post-Hospitalization Phase (Part III).
Presenter:
Samuel Z. Goldhaber, MD
OsteoporosisWRAP
: Aligning Patients with Therapy for Osteoporosis—A Case Study-Based Approach to Patient Management.
Presenter:
Felicia Cosman, MD
FibromyalgiaWRAP
: Landmark Trials, Clinical Challenges, and Practice Advances for FM Syndrome—Focus on Dual Reuptake Inhibition.
Presenter:
Don L. Goldenberg, MD
OAB-WRAP
: Focus on Early, Evidence-Based Management of Overactive Bladder—The Foundation Role of Muscarinic Receptor Antagonists.
Presenter:
David R. Staskin, MD
OsteoporosisWRAP
: Landmark Advances in Osteoporosis Management—Focus Zoledronic Acid and Hip Fracture Prevention.
Presenter:
Felicia Cosman, MD
Parkinson'sWRAP:
: The Foundation Role of MAO-B Inhibitors in Parkinson’s Disease.
Presenter:
Lawrence W. Elmer, MD, PhD
DiabetesWRAP
: Focus on 1,5-Anhydroglucitol (AG) for Monitoring and Clinical Management of Patients with Diabetes.
Presenter:
Steven D. Wittlin, MD
STI-WRAP
: Screening and Diagnosis of Sexually Transmitted Infections: Focus on Chlamydial Infections.
Presenter:
William M. Geisler, MD, MPH
KidneyStoneWRAP
: Diagnosis, Metabolic Risk Assessment and Long-Term Monitoring of Patients with Kidney Stones.
Presenter:
Glenn M. Preminger, MD
AsthmaWRAP
: NIH Asthma Guidelines—Laboratory Techniques for Identifying Allergic Triggers.
Presenter:
Leonard Fromer, MD, FAAFP
Surgery
CINV-WRAP
: Optimizing Therapy and Current Guidelines for Chemotherapy-Induced Nausea and Vomiting (CINV).
Presenter:
Lee S. Schwartzberg, MD, FACP
VTECancerWRAP
: Optimizing Clinical Outcomes for Venous Thromboembolism (VTE) in the Patient with Cancer.
Presenter:
Craig M. Kessler, MD, MACP
AnesthesiologyWRAP
: Landmark Advances in Minimal and Moderate Sedation-Focus on Fospropofol.
Presenter:
T.J. Gan, M.D.
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—DVT Risk Assessment and Pharmacologic Intervention Upon Hospital Admission (Part I).
Presenter:
Samuel Z. Goldhaber, MD
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—Dynamic VTE Risk Assessment During Hospital Admission (Part II).
Presenter:
Samuel Z. Goldhaber, MD
DVT-WRAP
: The Science and Medicine of VTE Prophylaxis—LMWH-based Prophylaxis in the Post-Hospitalization Phase (Part III).
Presenter:
Samuel Z. Goldhaber, MD
AntiplateletWRAP
: Oral Antiplatelet Therapy in the Setting of ACS—Focus on Thienopyridines and CABG Surgery.
Presenter:
Dr. Sunil V. Rao, MD, FACC
OsteoporosisWRAP
: Landmark Advances in Osteoporosis Management—Focus Zoledronic Acid and Hip Fracture Prevention.
Presenter:
Felicia Cosman, MD
KidneyStoneWRAP
: Diagnosis, Metabolic Risk Assessment and Long-Term Monitoring of Patients with Kidney Stones.
Presenter:
Glenn M. Preminger, MD
Osteoporosis
OsteoporosisWRAP
: Evidence-Based and Practical Approaches to Bisphosphonate Therapy.
Presenter:
Sol Epstein, MD
OsteoporosisWRAP
: Optimizing Fracture Reduction in Osteoporosis—The Role of Annual Cumulative Exposure with Bisphosphonates.
Presenter:
Steven D. Harris, MD, FACP
OsteoporosisWRAP
: Aligning Patients with Therapy for Osteoporosis—A Case Study-Based Approach to Patient Management.
Presenter:
Felicia Cosman, MD
OsteoporosisWRAP
: Landmark Advances in Osteoporosis Management—Focus Zoledronic Acid and Hip Fracture Prevention.
Presenter:
Felicia Cosman, MD
Anesthesiology
AnesthesiologyWRAP
: Landmark Advances in Minimal and Moderate Sedation-Focus on Fospropofol.
Presenter:
T.J. Gan, M.D.
Infectious Diseases
STI-WRAP
: Screening and Diagnosis of Sexually Transmitted Infections: Focus on Chlamydial Infections.
Presenter:
William M. Geisler, MD, MPH
